Six novel p53-inducible transcripts were recently cloned from Val5, a murine cell line stably expressing a temperature-sensitive p53 allele. One of the isolated clones represented a novel isoform of cytosolic adenylate kinase (AK1), a highly conserved monomeric enzyme involved in cellular homeostasis of adenine nucleotides. The corresponding protein, which we named AK1b, was speci®cally induced upon activation of wt p53 in Val5 cells. The AK1b protein diers from cytoplasmic AK1 by having 18 extra amino acids at the N-terminus. The extra residues in AK1b provide a consensus signal for Nterminal myristoylation; as expected, AK1b was shown to localize to the plasma membrane. The human AK1 gene contains several consensus p53 binding sites and we report that p53-dependent induction of the alternative AK1b transcript also occurs in human cells. By using antisense ablation experiments in Val5 ®broblasts we show that AK1b plays a relevant role in the establishment of reversible cell-cycle arrest as induced by p53 in these cells. These ®ndings suggest that within a p53-dependent genetic program, a speci®c isoform of adenylate kinase has a previously undescribed growthregulatory function, which might not necessarily require its best characterized biochemical activity.
Introduction
The p53 tumor suppressor gene is the most frequent target of genetic alterations yet identi®ed in human cancer (Hollstein et al., 1991 (Hollstein et al., , 1994 . A large body of convergent observations support the current view that wild-type (wt) p53 functions as a stress-response device, activating diverse anti-proliferative programs in response to a variety of stimuli (for review see Bates and Vousden, 1996; Hansen and Oren, 1997; Ko and Prives, 1996; Levine, 1997) . The best characterized signal¯owing to p53 is originated by DNA damage. p53 is activated in response to diverse types of DNA lesions such as those induced by gamma-irradiation, alkylating agents, or UV treatment (Zhan et al., 1993) .
But p53 can also respond to a variety of other stress conditions, such as hypoxia (Graeber et al., 1996) , heat/cold shock (Ohnishi et al., 1996) , depletion of ribonucleotides (Linke et al., 1996) and even treatment with Ca 2+ -phosphate precipitates (Renzing and Lane, 1995) . Depending on the stimulus, and on the cellular background, p53 can activate either cell-cycle arrest (which could be transient or permanent) or apoptosis (Di Leonardo et al., 1994; Hansen and Oren, 1997; Levine, 1997) . The biochemical mechanisms by which wt p53 exerts these activities have not been completely de®ned, but a fundamental aspect of p53 function depends on its activity as a transcription factor. p53 contains a strong transcriptional activation domain within its amino terminus and binds DNA through a well de®ned cognate binding sequence, activating transcription of genes carrying such consensus sites in their promoters (see Levine, 1997; Lin et al., 1994) . A massive eort has focused on identifying cellular genes regulated by p53; a number of interesting targets have already been described, and the list continues to lengthen (Ko and Prives, 1996) . Apart from transcriptional regulation, important aspects of p53 function are also mediated by speci®c transcriptional repression of several genes Sabbatini et al., 1995) , and growing evidence suggests that important functions of p53 require direct interaction with speci®c protein partners (Ko and Prives, 1996; Levine, 1997) . Focusing on the transcriptional activity of wt p53, it is reasonable to hypothesize that various target genes are dierentially induced by p53 to exert diverse biological eects. One important example is the p53-induced p21Waf1 protein, a potent inhibitor of G1-speci®c cyclin-dependent kinases which is largely responsible for the G1-arrest function of wt p53 (Deng et al., 1995; El-Deiry et al., 1993; Xiong et al., 1993) . Other p53-induced genes are directly or indirectly involved in apoptosis, angiogenesis, or G2/M cell-cycle arrest (reviewed in Ko and Prives, 1996) . It is conceivable that complex patterns of p53-regulated genes, acting on multiple pathways, cooperate to mediate the ®nal speci®c biological eect.
We recently performed a subtractive hybridization screening in Val5, a murine cell line stably expressing a temperature sensitive p53 protein, and thereby isolated six p53-inducible transcripts (Utrera et al., 1998) . At the permissive temperature, Val5 cells undergo p53-dependent cell-cycle arrest without any evidence of apoptosis. In particular, G1 arrest can be maintained for several days in culture, and is readily reversible when cells are returned to the non-permissive temperature (Del Sal et al., 1996; Utrera et al., 1998) . Thus, according to the above hypothesis, the pattern of gene expression induced by wt p53 in Val5 cells is instrumental in attaining a`reversible and prolonged cell-cycle arrest' phenotype. We report here that one of those transcripts encodes a previously undescribed form of adenylate kinase, displaying plasma membrane localization.
Adenylate kinase (Myokinase, EC 2.7.4.3) is a ubiquitous monomeric enzyme which catalyses the reversible transfer of phosphate between adenine nucleotides, according to the reaction ATP+ AMP$ADP+ADP (Noda, 1973) , and is fundamental in regulating homeostasis of adenine nucleotides in the cell. In vertebrates three isozymes have been characterized: AK1 is cytoplasmic; AK2 and AK3 are localized in the intermembrane space of mitochondria (Tanabe et al., 1993) . The alternative protein we describe is identical to cytosolic AK1, with only the addition of a N-terminal stretch of amino acids mediating membrane localization, possibly by lipid modi®cation.
The enzymology and molecular structure of cytoplasmic AK1 are well de®ned (see Byeon et al., 1995; Dreusicke et al., 1988) but very little is known about regulation of AK1 expression in ®broblasts, or about possible functions of AK1 in modulating cellcycle events. We describe antisense ablation experiments in Val5 suggesting that induction of the alternative AK1b protein plays a critical role in the kinetics of p53-induced cell-cycle arrest.
Results

Isolation of murine AK1 by subtractive hybridization
Val5 is a cell line derived from p53-de®cient Balb/c (10)1 mouse ®broblasts (Harvey and by stable transfection of the temperature sensitive Val135 allele of murine p53 (Martinez et al., 1991; Michalovitz et al., 1990) . At the permissive temperature of 328C these cells upregulate p53 transcriptional targets such as waf1 or mdm-2, and undergo an ecient and reversible G1 arrest (Del Sal et al., 1996) . During a dierential screening designed to detect novel p53-regulated genes, six cDNAs were isolated that are markedly induced by wt p53 in the Val5 cell line (Utrera et al., 1998) . One of the isolated clones, 1.1 Kb in length and provisionally named B110, corresponded to a transcript that was estimated to be approximately 2 Kb long according to Northern blot analysis ( Figure  1 ). No ORF was present, and database homology search did not reveal any similarity to known sequences. By further screening of the 328C-speci®c Val5 cDNA library using the B110 probe, two dierent nearly full-length clones were obtained. One of them, named B110.N6, corresponded to the murine homologue of cytosolic adenylate kinase, AK1 (EC 2.7.4.3). Indeed, the corresponding protein is encoded in a short Figure 1 Northern blot analysis of B110 mRNA expression and description of two corresponding clones. (a) B110 regulation in control cell lines. RNA was prepared from the indicated cell lines cultured at 378C or maintained at 328C for the indicated time. Balb/c(10)1 are murine ®broblasts with both p53 alleles deleted. Val5 are Balb/c(10)1 cells stably expressing the temperature sensitive Val135 mutant of murine p53. Val135(25 ± 26) are Balb/c(10)1 cells stably transfected with a derivative of the ts p53 Val135 carrying two additional point mutations (residues 25 and 26) that abrogate its transcriptional activation function. (b) B110 regulation in the absence of protein neosynthesis. Total RNA was prepared from Val5 cells grown at 378C or kept for 6 h at 328C in the absence or in the presence of 5 mg/ml of the protein synthesis inhibitor cycloheximide. (c) Regulation of B110 mRNA in UV treated mouse ®broblasts. Total RNA was prepared from NIH3T3 cells or p537/7 mouse embryo ®broblasts (MEF) 18 h after UV irradiation. WAF1 mRNA was analysed as a control of p53 activation. Levels of B110 and WAF1 are not comparable between the blots since exposure times were dierent. open reading frame not contained in the original B110 clone (see Figure 1) .
Induction of B110 mRNA is dependent upon p53 transcriptional function
Expression of the mRNA corresponding to clone B110 was analysed by Northern blot, comparing its regulation in Val5 cells (378 vs 328C) with its expression in the recipient Balb/c (10)1 and in Balb/c Val135(25 ± 26) cells. The Val135(25 ± 26) is a cell line derived from p53-null Balb/c (10)1 ®broblasts by stable transfection of a ts p53 mutant (Val135) carrying two additional point mutations in the transactivation domain that render it transcriptionally inactive (Lin et al., 1994) . As shown in Figure 1a , B110 mRNA was strongly induced in Val5 cells cultured at 328C for 12 or 24 h. No signi®cant variations in B110 mRNA levels were observed in the recipient Balb/c (10)1 cells at 328C, indicating that upregulation was not a consequence of temperature shift. Importantly, no induction of B110 mRNA was observed in Val135(25 ± 26) cells at 328C, when p53 is in wt conformation, binds to target sites on DNA, but is incapable of transcriptional activity (Lin et al., 1994) . This suggests that transactivation by wt p53 is required for enhanced expression of B110 mRNA. As a control, the same Northern blots were hybridized with a murine waf1 probe ( Figure 1a) .
To test whether the observed induction might be a secondary consequence of p53 activation, expression of B110 mRNA was analysed in Val5 cells in the absence of de novo protein synthesis. As shown in Figure 1b , B110 mRNA was clearly induced after 6 h at 328C, even in the presence of 5 mg/ml cycloheximide, as was waf1 mRNA analysed as a control. Under these conditions protein synthesis was efficiently inhibited, as determined by lack of p21Waf1 protein induction (not shown). Thus, p53-dependent accumulation of B110 mRNA occurs in the absence of protein neosynthesis, providing evidence that B110 is a direct transcriptional target of wt p53 in these cells.
To test whether B110 might be regulated by p53 under more physiological conditions, mRNA expression was analysed after stimuli known to activate endogenous p53 function in mouse ®broblasts. For this purpose NIH3T3 cells, which are wild type for p53 (Del Sal et al., 1995) , and ®broblasts from p53-nullizygous mice were treated with ultraviolet light (10 J/m 2 ) and B110 mRNA levels were analysed by Northern blot 18 h after irradiation. As shown in Figure 1c , signi®cant accumulation of B110 mRNA was detected in NIH3T3 while no induction could be observed in p53-null ®broblasts. A probe to waf1 was used as a control of p53 activation. Thus, UV induced DNA damage caused upregulation of B110 mRNA in a wt p53-dependent manner in murine cells.
wt p53 induces expression of an alternative AK1 mRNA As already mentioned, a second cDNA clone was isolated during the screening of the Val5 cDNA library with the B110 probe. This clone, named B110.N9, was determined by restriction analysis and partial sequencing to be almost identical to clone B110.N6, diering only in approximately 90 nucleotides in the 5' region. The structure of the two clones is schematically shown in Figure 1e . Conceptual translation of clone B110.N9 resulted in a deduced peptide starting from a dierent ATG on the same reading frame, and in which 18 extra amino acids are added to the N-terminus of the AK1 protein (see Figure 1e ). This alternative product was named AK1b.
To test if the identi®ed mRNA was actually expressed in Val5 cells at the permissive temperature, an antisense oligonucleotide designed on the 5' sequence of clone B110.N9 was used as a probe for Northern blot analysis. As shown in Figure 2a , the B110.N9-speci®c oligonucleotide probe recognized a regulated transcript, selectively expressed at 328C. This result con®rmed that the alternative form corresponding to AK1b was indeed expressed, and was eciently regulated by p53.
wt p53 induces expression of an alternative AK1 protein
To study AK1 expression at the protein level, a rabbit polyclonal antiserum was produced against porcine AK1. Expression of AK1 protein was analysed by immunoblotting on extracts from Val5 cells grown at 378 or 328C; as can be observed in Figure 2b , Lysates from Val5 grown at 378C or kept for 24 h at 328C were analysed by immunoblotting using either the anti-AK1 antiserum, which detects both AK proteins, or the anti-AK1b anity puri®ed antibody, which only detects the alternative AK1b protein cytoplasmic AK1 did not appear to be signi®cantly regulated. Rather, a slower migrating band detected by the same antibody was clearly accumulated at 328C, albeit with a signi®cantly slower kinetics than p21Waf1, analysed as a control. To better evaluate the regulation of both AK proteins, adenylate kinase was immunoprecipitated under denaturing conditions from Val5 cells grown at 378C or at 328C, after metabolic labelling with 35 S-methionine. As can be seen in Figure 2c , cytoplasmic AK1 was not strongly regulated, displaying a similar rate of synthesis at both temperatures. On the contrary, the slower migrating band was only detected at 328C, indicating speci®c induction. This band migrated with the same electrophoretic mobility of in vitro translated AK1b (not shown). This same band was speci®cally recognized by the anti-AK1 antibody, since it could not be detected when the serum was pre-incubated with puri®ed AK1 (Figure 2c ). Therefore, upon activation of p53 function in Val5 cells, a slower migrating form of AK1 was speci®cally induced, possibly corresponding to the alternative protein encoded by clone B110.N9.
We next produced a polyclonal antiserum against a synthetic peptide corresponding to the ®rst 15 amino acids of AK1b. This antibody was anity puri®ed on the respective peptide, and used for immunoblotting on extracts of Val5 cells. As shown in Figure 2d , the AK1b-speci®c antiserum detected a protein selectively expressed at 328C in Val5. Taken together, these results strongly imply that the slower migrating band recognized by the anti-AK1 serum was indeed AK1b.
The alternative AK1b protein is localized to the plasma membrane
Analysis of the N-terminal extra amino acids of AK1b suggested the presence of a putative signal for Nmyristoylation; in fact, as shown in Figure 3a , the Nterminus of AK1b contains the conserved residues involved in myristoylation (and palmitoylation) of srclike protein kinases and a subunits of heterotrimeric Gproteins (see Resh, 1994) . Co-translational addition of myristate at the N-terminus of these proteins has been reported to be required for their localization to the membrane compartment; therefore, we addressed the possibility that AK1b could be a membrane-associated form of adenylate kinase.
To compare the intracellular localization of AK1 and AK1b, the two proteins were fused to a C-terminal Vesicular Stomatitis Virus (VSV) tag. These constructs were cloned in a mammalian expression vector and transfected in COS-7 cells. Transfected proteins were stained with a monoclonal antibody to the VSV epitope and analysed by confocal microscopy. As shown in Figure 3b , the AK1 protein exhibited a diused cytoplasmic pattern of staining. On the contrary, the longer AK1b protein displayed a clear membrane-bound localization.
To biochemically con®rm the membrane localization of the AK1b protein, dierential fractionation was performed to separate cytoplasmic from membrane associated proteins. Brie¯y, cells were collected in isotonic buer, lysed by sonication, and fractionated by centrifugation on a sucrose gradient. Cytosolic and membrane fractions were subsequently analysed by immunoblotting with the anti-AK1 and the AK1b-speci®c antisera. As can be observed in Figure 3c , AK1b speci®cally segregated with the membrane fraction. To con®rm purity of the fractions, endogenous Fyn, which is associated to the membrane via N-myristoylation (Koegl et al., 1994) , and tubulin, which is largely cytoplasmic, were analysed in the same samples. Taken together, these Figure 3 The alternative AK1b protein is localized to the plasma membrane. (a) Alignment of the N-terminus of AK1b with several myristoylated proteins. The upper block includes members of the src-like family of protein kinases. The lower block includes the Ga subunits of trimeric G-proteins. The highly conserved residues are shaded. (b) Cellular localization of ectopically expressed AK proteins. COS-7 cells were transfected with plasmids expressing VSV tagged AK1 or AK1b proteins. Twenty-four hours later cells were ®xed, stained with a monoclonal anti-VSV antibody, and photographed using a confocal microscope. (c) Biochemical localization of endogenous AK proteins in Val5. Immunoblotting of puri®ed cytoplasmic (C) and membrane (M) fractions from Val5 cells grown at 378C or kept for 24 h at 328C (see Materials and methods). Equal amounts of lysates from cells growing at the two temperatures were separated by SDS ± PAGE, transferred to nitrocellulose, and stained with the indicated antibodies. Cytoplasmic and membrane fractions are not comparable with each other because of dierent dilution data demonstrate that AK1b is localized to the plasma membrane, as could be inferred from its primary sequence.
Evidence for an involvement of AK1b in wt p53-dependent cell-cycle arrest
To evaluate the biological relevance of AK1b induction in the context of p53 function, an antisense approach was used in the Val5 cell line as described previously (Del Sal et al., 1996) . Expression vectors containing the 3'UTR region of AK1 in either sense or antisense orientation were microinjected in Val5 cells at 378C, along with a vector expressing the human transferrin receptor (hTR) as a marker to score injected cells. After microinjection, the cells were shifted to 328C and the percentage of cells in S phase was measured by BrdU incorporation after 22 h (Figure 4a ). At this time point Val5 cells undergo p53-dependent cell cycle arrest, and only 10 ± 15% of cells are in S phase, as compared to the average 50% of S phase cells detected at 378C (Figure 4b ). Cells injected with the antisense construct (AS) arrested less eciently, displaying a much higher proportion of cells in S phase than the background uninjected cells (Figure 4b ). This dierence was less evident at longer times, and by 48 h at 328C, both injected and uninjected cells had growth arrested (not shown). The extent of interference in the induction of cell-cycle arrest can be expressed as percentage delay (i.e. per cent S phase of injected cells minus per cent S phase of uninjected cells, divided by per cent S phase of uninjected cells) as shown in Figure 4c . Similar results, albeit less striking, could be obtained using the coding region of AK1 in antisense orientation (ORF). Plasmids expressing the VSV tagged versions of either AK1 or AK1b were co-injected at 50 ng/ml with the 3'UTR construct in either sense or antisense orientation as described in (a). Results, expressed as Delay(%), are the mean of at least three independent experiments in which more than 100 injected cells were analysed Injection of hTR alone had no eect, neither did injection of the 3'UTR of AK1 in sense orientation (SE). It is worth noting that similar results were obtained with an antisense construct to Waf1 under the same experimental conditions (Del Sal et al., 1996) ; thus, it appears that expression of antisense AK1 interferes with wt p53 induced cell-cycle arrest in Val5 cells.
Co-expression of AK1b neutralizes the eect of antisense 3'UTR constructs Based on our observations, it would appear that wt p53 is speci®cally inducing AK1b rather than the cytoplasmic form AK1, which is constitutively expressed. Since antisense 3'UTR constructs are complementary to both AK forms, we reasoned that antisense RNAs were more likely interfering with AK1b induction, rather than depleting cytoplasmic AK1. To test this hypothesis, we decided to evaluate the ability of each AK protein to neutralize the eect of expression of antisense 3'UTR. We performed a triple co-injection in which expression vectors containing VSV-tagged versions of either AK1 or AK1b were microinjected along with the antisense 3'UTR construct and the hTR marker. It is important to point out that there was no overlap between the coding regions and the antisense 3'UTR fragment used (see Figure 4d ). As summarized in Figure 4e , co-expression of cytoplasmic AK1 had no eect on the inhibition of cell-cycle arrest by antisense 3'UTR. On the contrary, co-expression of AK1b reversed the eect of antisense 3'UTR, and injected cells arrested as eciently as background uninjected cells. Indirect immuno¯uorescence con®rmed that AK proteins were actually expressed within injected cells (not shown). Overexpression of either AK1 or AK1b alone had no eect on the cellcycle pro®le of Val5 cells at 378C (not shown). Coexpression of either AK1 or AK1b together with the 3'UTR in sense orientation did not in¯uence the cellcycle arrest of Val5 cells at 328C (Figure 4e ). These results strongly imply that the delay in p53-induced arrest observed in Val5 cells following injection of antisense AK constructs is the consequence of blocking p53-dependent induction of the alternative AK1b protein.
The alternative form of AK1 mRNA is induced by p53 in human cells
The human gene for cytosolic adenylate kinase has been sequenced and characterized (Matsuura et al., 1989) : it is composed of seven exons spanning a region of about 12 Kb on chromosome 9 q34.1 ± q34.2. Through a computer based analysis of the human AK1 gene, we and others could identify several putative p53 binding sites, both within the promoter and intronic sequences (Bourdon et al., 1997) . These elements are detailed in Table 1 and their positions within the human AK1 gene are indicated in Figure 5a . There is a cluster of degenerated decameric sites in the promoter, at approximately 500 bp from the transcription start site; two putative p53-responsive elements are located within the ®rst intron, and another cluster of decamers is located in the second intron. The presence of putative p53 responsive elements in the human AK1 gene provides conceptual support for the observed p53-dependent regulation of the murine gene; moreover, it strongly implies that human AK1 might also be regulated by p53.
Within intron 2, a region could be identi®ed having high similarity to the alternative 5' sequence of clone B110.N9; this region is indicated as exon IIb in Figure  5a . This sequence is surrounded by consensus sites for splicing (not shown). Notably, if this putative exon IIb was joined to exon 3, an alternative form of human AK1 would be generated, perfectly corresponding to murine AK1b. Indeed, computer search of the dbEST database identi®ed a human cDNA (EST clone 781374, Accession number AA430294) which exactly corresponded to the hypothesized alternative transcript, thus con®rming its existence in human cells. Figure 5b shows the N-terminal alignment of the deduced murine and human peptides: although the primary sequences are not identical, the residues involved in putative myristoylation are strikingly conserved, suggesting that the principal function of the peptide encoded by exon IIb is to provide membrane localization. These observations indicate that EST clone 781374 might be the human homologue of murine AK1b.
To evaluate if the alternative form of AK1 is regulated by wt p53 in human cells, expression of AK1b was analysed by semi-quantitative RT ± PCR on two dierent cell lines carrying a temperature sensitive allele of either murine or human p53 (see legend to Figure 5 ). An upper primer was designed on exon IIb and a lower primer was designed within exon 6 to yield a speci®c product of 400 bp. Ampli®cation products were Southern-blotted and detected using a speci®c internal probe. Regulation of AK1b mRNA was then compared to regulation of GAPDH ampli®ed from the same cDNA. As shown in Figure 5c , the transcript corresponding to the alternative AK1b protein was selectively detected only at the permissive temperature in both cell-lines. To extend this observation to a more (7495) GGTCCTGGCC AGGGCCTCT GGGCAGGCTC TGA GGGCGGGCTT GG GGACTGTGG C CAGCAaAGCCC 2.
(+524) GGGCTTGCCT T GGCCTTGTCT 3.
(+1169) CAGCAaAGCCA CTT CAGCTGCTA CTGGGTGCCA GGCCCAGCGT AGCAGAAACT CAG GGCCGAGTTG GACCC TAGCTGGCCC TC GAACCAGTCT 4.
(+3994) GGACGAGACA GAGGTTGG AGCCAAGCTC ACCGCCCTCTCT GGGCAAGAGT T CCACATGCCC a Sites are numbered as in Figure 5a .
b The position of each sequence is indicated with respect to the transcriptional start site (+1) physiological system, expression of AK1b was also analysed in human ®broblasts after exposure to UV irradiation. Under these conditions p53 function was eciently activated (M Monte, unpublished results). Accordingly, AK1b was signi®cantly induced by UV treatment, both in embryonic ®broblasts and IMR90 cells (Figure 5c ). Taken together, these data demonstrate that a human AK1b transcript exists, and suggest that such a transcript is also regulated by wt p53 in a manner similar to that observed with the murine gene.
Discussion
Identi®cation of transcriptional targets of wt p53 is critical for understanding the pathways by which p53 elicits its eects on cells. Accumulating evidence suggests that p53 can regulate a number of target genes, acting on diverse cellular processes, thereby mediating reversible/long term cell-cycle arrest or apoptosis (see Komarova et al., 1998; Madden et al., 1997; Polyak et al., 1997) . We recently cloned six novel transcripts upregulated by a temperature sensitive p53 in Val5 murine ®broblasts (Utrera et al., 1998) . At the permissive temperature, Val5 cells undergo a robust, reversible, p53-dependent growth-arrest with no evidence of apoptosis. Therefore, genes induced by p53 in this experimental system are good candidates for being involved in the cell-cycle arrest function of wt p53.
Here we have reported that one of those clones encoded a novel, alternative form of cytosolic adenylate kinase (AK1, EC 2.7.4.3), diering from AK1 by having 18 extra amino acids at the Nterminus. We named this alternative product AK1b and we could demonstrate that the AK1b protein is speci®cally upregulated in Val5 cells upon wt p53 activation.
A number of observations indicate that AK1b might be a direct and speci®c transcriptional target of p53; ®rst, upregulation of the transcript required a transcriptionally competent p53; second, ecient induction of the mRNA was observed in Val5 cells even in the absence of protein neo-synthesis; and ®nally, AK1b mRNA was upregulated in a wt p53-dependent manner in mouse ®broblasts exposed to UV irradiation. Additional support to this inference was Table 1 ). Exons are numbered according to Matsuura et al. (1989) (Vikhanskaya et al., 1994) . AT-6 are U2OS osteosarcoma cells, transfected with the Val143 ts mutant of human p53 (Buckbinder et al., 1994) . At 328C the exogenous p53 in these cells assumes a wt conformation and induces expression of target genes. Expression of human AK1b was also analysed in human embryonic ®broblasts (HF) and IMR90 cells after 10 J/m 2 UV irradiation. Identical aliquots of random primed cDNA were used for PCR ampli®cation with primers speci®c for human AK1b or GAPDH. Reaction products were analysed by Southern blotting using speci®c probes provided by analysis of the human AK1 gene: in fact, a number of consensus p53-binding sites are located in the promoter and ®rst introns of human AK1 (see Figure 5) , and some of them may be conserved in the murine gene. Importantly, we showed that a human transcript corresponding to AK1b exists and is speci®cally upregulated by wt p53 in human cells. This last observation has two important implications: it demonstrates that at least one of the putative p53-responsive elements is functional, con®rming the validity of the sequence-based predictions, and it demonstrates that p53-dependent upregulation of AK1b is evolutionarily conserved, supporting its possible biological signi®cance. A detailed molecular analysis will be required to clarify which are the functional p53-responsive elements in the AK1 gene and to de®ne the molecular basis for expression of the alternative AK1b transcript.
The extra amino acids at the N-terminus of murine and human AK1b contain a consensus signal for myristoylation, a lipid modi®cation known to mediate protein targeting to the cell membrane (Resh, 1994) . Accordingly, we could show by immuno¯uorescence that exogenous AK1b localizes to the plasma membrane. By biochemical analysis we con®rmed that endogenous AK1b segregates with the membrane fraction. In most myristoylated proteins, such as srcfamily members (except Src itself and Blk) and Ga subunits of heterotrimeric G-proteins, membrane association is stabilized by attachment of palmitate to the thiol group of N-terminal cysteine residues, a reaction which is subordinated to co-translational addition of myristate on Gly 2 (Bhatnagar and Gordon, 1997; Koegl et al., 1994; Resh, 1994) . Given that N-terminal cysteine residues are present at appropriate positions and are conserved in both murine and human AK1b proteins (see Figures 3 and  5) , it is possible that membrane association of AK1b is also reinforced by palmitoylation.
Addition of extra amino acids at the N-terminus should not dramatically aect the substrate binding region of adenylate kinase. In fact, crystallographic data on the structure of porcine cytosolic AK1 (extremely similar to both human and murine AK1) indicate that the N-terminus and the C-terminus point to the outside of the molecule (Dreusicke et al., 1988; Schulz and Schirmer, 1974) . This suggests that AK1b should maintain ATP : AMP phosphotransferase activity.
The biological relevance of AK1b induction in the context of p53-dependent growth-arrest was demonstrated by antisense ablation experiments in Val5 cells. Expression of an antisense mRNA corresponding to the 3'UTR of AK1 (and AK1b) signi®cantly delayed p53-induced cell-cycle arrest of Val5 at 328C, and this eect could be eciently reversed by co-expression of the AK1b protein, but not by cytoplasmic AK1. Thus, AK1b most likely has a novel function with respect to AK1, and this function is probably related to p53-modulated biochemical events determining cell-cycle arrest.
A ®rst hypothesis to connect AK1b biochemical activity with its biological eect is that p53-dependent upregulation of adenylate kinase serves to provide ATP backup to energy-consuming processes such as DNA repair or apoptosis. However, we do not favour such an hypothesis, since the eect of antisense 3'UTR could not be reverted by coexpression of even high amounts of cytosolic AK1, indicating that a function exclusive to AK1b is required. Nevertheless, it is still possible that membrane targeting serves to locally increase AK activity at sites where it might be speci®cally required. In bacteria, for example, a fraction of AK1 is membrane-associated and is involved in energy consuming activities such as phospholipid neosynthesis, or transport of osmoprotectants during osmotic shock (Gutierrez and Csonka, 1995; Watanabe et al., 1986) .
A second hypothesis is that re-localization of AK1 to the membrane compartment, or the mere addition of extra amino acids at the N-terminus, could modulate the substrate speci®city of the enzyme. It is in fact known that AK1 can complement nucleoside diphosphate kinase (NDPK) de®ciency in bacteria (Lu and Inouye, 1996) , and that mammalian AK1 has full NDPK activity and can eciently phosphorylate all four ribo-or deoxyribo-nucleosides diphosphates (Lu and Inouye, 1996) . In Pseudomonas aeruginosa, under certain growth conditions, cytoplasmic NDPK is proteolytically converted to a membrane-associated form which acquires a strong speci®city for synthesizing GTP in preference to other NTPs (Shankar et al., 1996) . Similarly, AK1b could have a more selective substrate speci®city than AK1. Crucial events take place at the inner face of the membrane, where signals coming from the external environment are integrated in multiple transducing pathways, regulating processes such as celldivision, cell-dierentiation, or cell-death (see Hunter, 1997; Van Aelst and D'Souza-Schorey, 1997) . Many important signalling events involve protein phosphorylation or GTP hydrolysis and it is plausible that the local concentrations of adenine and guanine nucleosides di-or three-phosphates in¯uence such processes; AK1b might therefore regulate homeostasis of ATP or GTP at the sub-membrane compartment.
A third hypothesis is that re-localization of AK1 to the membrane compartment facilitates functional interaction with other proteins. Notably, in Ga proteins the N-terminal anchor participates in interaction with the Gbg subunits (Conklin and Bourne, 1993; Lambright et al., 1994) . It is therefore tempting to speculate that in AK1b the extra amino acids at the Nterminus might create a docking site for protein ± protein interactions. Furthermore, AK1 protein is known to undergo signi®cant conformational changes during the catalytic cycle (see Dreusicke et al., 1988; Gerstein et al., 1993) . This conformational switch might transduce a signal to hypothetical interacting proteins, similarly to what happens with G proteins and smallGTPases (Hall, 1998; Hepler and Gilman, 1992) . It is worth noting that a possible eect of p53 on signal transducing pathways has already been hypothesized; in fact human p53 induces the RGS14 member of the RGS family of regulators of G-protein signalling (Koelle, 1997) . RGS14 interacts with Ga subunits and inhibits G-coupled growth-factor receptor mediated activation of mitogen-activated kinases (Buckbinder et al., 1997) .
A ®nal hypothesis is that addition of the extra residues and consequent re-localization to the membrane compartment might provide AK1b with a novel biochemical function, distinct from that of ADP kinase, such a function being involved in p53-dependent cellcycle arrest. For example, the Nm23 metastasis-suppressor genes encode NDP kinases (see De la Rosa et al., 1995; Engel et al., 1998 for review) and a few reports suggest that NDPK activity is dispensable for their metastasis suppressing function (Engel et al., 1995; Lascu et al., 1992; MacDonald et al., 1993) . A recent study revealed that Nm23-H1 forms a complex with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in vivo, and such a complex has ser/thr-speci®c protein phosphotransferase activity (Engel et al., 1998) . Although the relevance of this novel activity for the metastasis-suppressing function of Nm23-H1 is still to be assessed, it provides a remarkable example of an`old' enzyme acquiring a`novel' function.
In conclusion, Val5 cells are an excellent model for studying the cell-cycle arrest function of wild type p53. Within this cellular system we have observed involvement of a membrane-associated form of adenylate kinase in a growth-regulatory pathway activated by p53. Future work will be aimed at extending the possible relevance of AK1b expression to other cellular systems, and to test the various aforementioned hypotheses on AK1b function in the context of p53-dependent cell-cycle arrest.
Materials and methods
Cell lines and culture conditions
All cell lines were routinely cultured at 378C in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), penicillin (100 U/ml) and streptomycin (100 mg/ml). UV treatment consisted in a 10 J/m 2 irradiation as described in Del Sal et al. (1996) .
Northern blotting
For Northern blotting, RNA samples were separated on 1% agarose gels containing 2.6% formaldehyde. 10 mg of total RNA were loaded on each lane, RNA was transferred to nylon membranes according to the protocol described by Chomczynski (1992) , and hybridization was performed under high stringency conditions. The oligonucleotide probe used to detect the alternative AK1b mRNA in Northern blots had the following sequence: 5'-GGTTCACTAGACACACA GCAGCCCATGATCCTA-3'.
DNA sequencing
DNA sequencing was performed on an automated¯uorescent DNA sequencer (European Molecular Biology Laboratory; EMBL) using the T7-Sequencing Kit (Pharmacia). Sequence assembly and analysis was done using the Geneskipper V1.1 software (EMBL).
Production of polyclonal antisera, immunoblotting and immunoprecipitation
Puri®ed porcine AK1 was purchased from Sigma. Rabbits were injected with 200 mg of denatured AK1 cut out from a 15% acrylamide/SDS electrophoresis gel, mixed 1 : 1 with complete Freund's adjuvant (Sigma). The same amount of protein was subsequently injected every 21 days for 4 months. The synthetic peptide (N-CVSSEPQEEGGRKTGEKL-C) corresponding to the alternative N-terminal sequence of AK1b was conjugated to Keyhole Limpet Haemocyanin (Sigma) and 200 mg of peptide-KLH mixed 1 : 1 with Freund's adjuvant were injected every 21 days for approximately 6 months.
Immunoblots were routinely performed at RT in BlottoTween under standard conditions. Fyn was detected using a rabbit polyclonal anti-Fyn antibody (Santa Cruz). Tubulin was detected using a monoclonal antibody anti-a tubulin (Sigma). Primary antibodies were revealed with horseradish peroxidase (HRPO)-conjugated secondary antibodies (Southern Biotechnology). Blots were developed with the ECL chemioluminescence system (Amersham).
For immunoprecipitation, Val5 cells were labelled with 35 S-methionine for 4 h. Cells were scraped in denaturing buer (0.8% SDS, 150 mM NaCl, 50 mM Tris pH=7.5) and boiled for 5 min. SDS was subsequently quenched by adding one volume of quenching buer (4% Triton X-100, 150 mM NaCl, 50 mM Tris pH=7.5) containing protease inhibitors. After preclearing, the crude anti-AK1 serum was added and incubated overnight at 48C. Immune complexes were then collected on Protein A-sepharose beads (Pharmacia), separated by SDS ± PAGE, and exposed to autoradiography.
Preparation of membrane and cytosolic fractions
Membranes and cytosol fractions were prepared as described (Kaufman et al., 1996) , with minor modi®cations. Subconuent Val5 cells were scraped in ice-cold phosphate-buered saline (PBS) and pelleted by centrifugation. Cells were resuspended in 1 ml of 6% (w/w) sucrose 710 mM PIPES, pH 7.2 plus protease inhibitors, and disrupted by sonication. Sonicated cell extracts were centrifuged at 600 g for 3 min to remove nuclei and unbroken cells. Supernatants were loaded on sucrose gradients prepared by layering 2 ml of 47, 40, 30 and 20% sucrose on a 55% cushion and centrifuged at 200 000 g for 2 h. The top cytosol fraction and the 20 ± 30% interface were collected. The latter was pelleted at 100 000 g for 30 min and resuspended in 9% sucrose containing proteinase inhibitors. Protein concentrations were measured by the Bradford assay (BioRad) and equal amounts of extracts from the two growth-conditions were loaded for each fraction.
Immuno¯uorescence microscopy
Cells were plated on glass coverslips within 3 cm tissue culture dishes. After washing with PBS, cells were ®xed in PBS/3%PFA for 20' at RT, treated with PBS/1% glycine for 5', and permeabilized in PBS/0.1% Triton X-100 for 5' at RT. AK1 proteins were detected with a monoclonal anti-VSV antibody (Sigma) followed by a goat anti-mouse FITCconjugated antibody (Sigma). Human TR was detected using the OKT-9 monoclonal antibody. For S phase quantitation, cells were incubated with 50 mM BrdU prior to ®xation, and a short treatment with 50 mM NaOH was performed to denature DNA before incubation with primary antibodies. BrdU was detected using a monoclonal IgG2a antibody (Amersham). After incubations and extensive washes, coverslips were mounted on glass slides and analysed using a laser scan confocal microscope (Zeiss).
RT ± PCR analysis of human AK1 transcripts
Random primed cDNAs were produced from 10 mg of total RNA. Dilutions of the cDNA were prepared and identical aliquots were used for PCR ampli®cation with two separate set of primers. The alternative 5' end of human AK1b was ampli®ed using the primers UP: 5'-GGAATTCGACCATGG-GCTGCTGCTC-3', and LO: 5'-GGAATTCGCAGCAGTG-TGGGCTGTC-3'. An internal fragment of human GAPDH was ampli®ed using the primers UP: 5'-CATGCCATCACTG-CCACCC-3', and LO: 5'-ACCTGGTCCTCAGTGTAGC-3'. Ampli®cation products were separated on agarose gels and analysed by Southern blotting using either a probe corresponding to the ORF of murine AK1 (cross-reactive to human AK1b) or a probe corresponding to rat GAPDH.
